• Bio-IT World Best of Show Finalists Named

    Bio-IT World| Finalists have been named for the 2025 Bio-IT World Best of Show Awards program. More than 20 new products will be on display next week at the Bio-IT World Conference & Expo. New products will be on display from Artificial, Boulder BioComputing, Copyright Clearance Center, Chemspace, Dantech Corporation, Discngine, expert.ai, Genomenon, Globus, GRAU DATA, iuvo, Komprise, Orchestra Bio, Quantum Corporation, QuartzBio, Sinequa, Tech Mahindra, TetraScience, The Hyve, and Velsera.

    Mar 28, 2025

  • Pistoia Alliance Reducing Carbon Footprint, Thermo Fisher Next-Gen Hybrid Capture Assay, More

    Bio-IT World| The Pistoia Alliance launched the next phase of its project to measure and reduce the carbon footprint of clinical trials; the Lupus Research Alliance announced the inaugural recipients of the new Targeted Research Program on Engineered Cell Therapies for Lupus; and more.

    Mar 27, 2025

  • Follow the Money: Gene Editing Therapeutics, Breast Cancer AI Predictive Platform, More

    Bio-IT World| Arbor Biotechnologies will advance its pipeline of novel gene editing therapeutics targeting diseases in the liver and central nervous system; Ataraxis AI will further the development of Ataraxis Breast, the world’s first AI-native prognostic/predictive platform for breast cancer; and more.

    Mar 26, 2025

  • Elsevier Launches AI Search, Summary, Comparison Tool for ScienceDirect

    Bio-IT World| Last week, Elsevier launched ScienceDirect AI, a generative AI tool for researchers that will extract, summarize and compare trusted insights from millions of full-text articles and book chapters on ScienceDirect.

    Mar 20, 2025

  • Bio-IT World Names Innovative Practices Winners

    Bio-IT World| Bio-IT World has named the 2025 Innovative Practices Awards winners, choosing to honor four entries. Winners this year include Genmab nominated by Genedata, NHS England nominated by IQVIA, Pistoia Alliance, and Regeneron. The judging panel also highlighted two entries for Honorable Mention: a separate entry from Pistoia Alliance and Quris-AI.

    Mar 19, 2025

  • Flatiron Health Enables Patient-Level Data Sharing Across National Borders

    Bio-IT World| Patient-level real-world data (RWD) derived from harmonized electronic health records (EHRs) across four countries will help power multinational oncology research of the future, thanks to groundbreaking, collaborative efforts of Flatiron Health scientists working in the U.S., UK, Germany, and Japan.

    Mar 18, 2025

  • ‘Therapeutic Blood Clots’ Could Remedy Cartilage Loss from Osteoarthritis

    Bio-IT World| Scientists at the University of Wisconsin – Madison believe it could soon be possible to use people’s own blood clots to treat bone-on-bone osteoarthritis by having the material be the scaffolding that fills the space where cushioning cartilage used to be. The plan is to have the clots serve as a temporary matrix that cells will infiltrate to be exposed to a gene that encourages them to form hyaline cartilage.

    Mar 13, 2025

  • New Healthcare Security Benchmark Highlights Key Investment Priorities and Risks

    Bio-IT World| At a session in the Cybersecurity Pavilion of ViVE last month, Cormac Miller, President and CCO of Censinet, presented the company’s 2025 cybersecurity benchmark for the healthcare sector. This year’s benchmark revealed that for the third year in a row, organizations are focusing on respond and recover capabilities.

    Mar 12, 2025

  • Venture Capital Needed to Fill Gaps Left by Uncertain Government Funding

    Bio-IT World| Altitude Lab, the nonprofit formed by clinical-stage biotech company Recursion, recently launched a pre-seed venture fund to help 10 to 15 early-stage startups get through the current “period of uncertainty” around government funding—and other private investment groups will ideally follow suit over the short term.

    Mar 11, 2025

  • Pan-European Genomic Reanalysis Effort Yields Over 500 Diagnoses

    Bio-IT World| A groundbreaking collaborative effort spanning 12 European countries and Canada has successfully identified genetic causes for more than 500 previously unsolved rare disease cases. Led by the University of Tübingen in Germany, the Solve-RD (Solving the Unsolved Rare Diseases) consortium brought together 300 experts from 37 institutions to leverage advanced genomic reanalysis techniques, ultimately providing long-awaited answers to patients and their families.

    Mar 6, 2025

  • High-Performance Computing in the AI Era: Challenges and Future Prospects

    Bio-IT World| In an era where artificial intelligence (AI) dominates discussions in technology, high-performance computing (HPC) remains the backbone of scientific discovery and enterprise research. Despite its critical role, HPC often operates in the background, much like electricity—only noticed when it fails. On the latest Trends from the Trenches Podcast, Dirk Petersen, Director of the Supercomputing Center at Oregon State University, shared his insights on the evolving role of HPC and its integration into AI-driven research.

    Mar 5, 2025

  • AI to Democratize Access to Cheap, High-Throughput Cardiotoxicity Testing

    Bio-IT World| Researchers have trained an artificial intelligence (AI) model to reconstruct the electrical signals inside of heart cells based on recordings taken from outside those cells, opening the possibility of cheap, high-yielding cardiotoxicity testing using commercially available microelectrode arrays. The hope is that the U.S. Food and Drug Administration (FDA) will allow the tool to be used in lieu of inserting pipettes into cells to record signaling changes with the addition of a drug, which is both costly and cumbersome to do at scale.

    Mar 4, 2025

  • The False Dichotomy of Short Reads vs. Long Reads

    Bio-IT World| The rate of evolution of DNA sequencing technologies since the introduction of the Sanger method in the 1970s has been astounding. It’s just over 20 years since the publication of the first draft human genome and today, technologies can deliver that same information for as little as $100.

    Feb 28, 2025

  • RNA in Oncology Research, Ultima Genomics Commercially Launches Platform, More

    Bio-IT World| InfoBionic.Ai’s MoMe ARC delivers real-time cardiac insights, empowering physicians to improve patient outcomes; Ultima Genomics announced the commercial launch of UG 100 Solaris; and more.

    Feb 27, 2025

  • Follow the Money: 3D Spatial Biology, AI-Powered Imaging Biomarkers, More

    Bio-IT World| Stellaromics commercializes their 3D spatial biology platform, Pyxa; Latent Labs’ AI platform shows promising potential to open new paths to personalized medicines; and more.

    Feb 26, 2025

  • Eli Lilly’s CISO Andrea Abell on Safeguarding Innovation in Pharma

    Bio-IT World| Earlier this week at the ViVE conference in Nashville, Tenn., Bio-IT World editor, Allison Proffitt, sat down with Andrea Abell, Eli Lilly’s Chief Information Security Officer (CISO), whose mission is to protect the integrity of pharmaceutical research from inception to patient delivery. Together they discussed the critical role cybersecurity plays in Lilly’s broader goal of bringing life-changing medicines to market.

    Feb 20, 2025

  • Illumina’s New Spatial Products

    Bio-IT World| Today, Illumina announced a new spatial technology program of Illumina sequencers and a multimodal analysis platform. The company also announced a collaboration with the Broad Institute on spatial transcriptomics. Illumina's spatial technology delivers unbiased whole-transcriptome profiling with cellular resolution and high sensitivity.

    Feb 19, 2025

  • AI in Healthcare: How To Assess What Works

    Bio-IT World| At a panel discussion this week at the ViVE conference in Nashville, Tenn., researchers and physicians discussed the promise and hype of AI. Moderated by Alexander Morgan, partner at Khosla Ventures, the discussion was wide ranging and discussed the AI tools ready for use by physicians; which classes of AI are not yet delivering; and how to assess what’s right for you.

    Feb 18, 2025

  • Ultima Genomics Sequencing Platform Selected for UK Biobank Study

    Bio-IT World| Last month, Ultima Genomics announced that their UG 100 sequencing platform was selected by UK Biobank to be used in their human proteomics study, which is anticipated to be the largest and most comprehensive proteomics study to date. The study is intended to quantify more than 5,400 protein markers across 600,000 samples, which will help researchers understand how protein levels fluctuate over time and how these changes correlate with disease progression and aging.

    Feb 14, 2025

  • Epigenetics Alone Can Alter Cancer Susceptibility

    Bio-IT World| Evidence is emerging that epigenetic differences prior to birth can signal the type of cancer that occurs decades later by dictating which mutated cells turn into a tumor. It is “underappreciated” that most otherwise healthy people are walking around with cancer-causing mutations that their body suppresses unless their built-in defense system mysteriously fails.

    Feb 13, 2025